Kroegel C, Kortsik C, Kroegel N, Matthys H
Albert-Ludwigs-University, Department of Pneumology, Robert-Koch-Clinic, Freiburg, Federal Republic of Germany.
Drugs Aging. 1992 Jul-Aug;2(4):345-55. doi: 10.2165/00002512-199202040-00007.
Platelet activating factor (PAF) is a unique phosphoglyceride which possesses many potent biological activities relevant for the pathogenesis of diseases of the elderly. PAF is generated and released by numerous cell types and tissues and is rapidly metabolised through a well defined metabolic cycle. Its biological actions are mediated via direct and indirect stimulatory effects on target cells and tissues. The current knowledge of PAF and its role in cardiovascular disease, thromboembolism, cerebral ischaemia and neurodegenerative disorders are discussed in detail. It is likely, that in future, a better understanding of the pathophysiological and physiological roles of PAF will provide new strategies for the treatment of human diseases of aging.
血小板活化因子(PAF)是一种独特的磷酸甘油酯,具有许多与老年人疾病发病机制相关的强大生物活性。PAF由多种细胞类型和组织产生并释放,并通过一个明确的代谢循环迅速代谢。其生物学作用是通过对靶细胞和组织的直接和间接刺激作用介导的。本文详细讨论了目前关于PAF及其在心血管疾病、血栓栓塞、脑缺血和神经退行性疾病中的作用的知识。未来,对PAF的病理生理和生理作用有更好的理解可能会为治疗人类衰老相关疾病提供新的策略。